CD4 and neoplasm: Analysis of tumor‐infiltrating lymphocytes (TILs) by IHC staining showed that Y‐27632‐treated or anti‐PD‐1 antibody‐treated tumor had significantly increased CD4+ and CD8+ T‐cell infiltration (Fig. 5C,D).